GlassScriptPhysician profile
David R Squires
NPI 1376520148
$32,704.56
in general payments reported to CMS, 2019-2025
89 companies · $7,861 in 2025
The $7,861 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,560 · 2020: $2,258 · 2021: $2,441 · 2022: $2,008 · 2023: $5,128 · 2024: $10K · 2025: $7,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $10K · Travel and Lodging: $1,726 · Education: $424 · Gift: $19.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,818.00 |
| Food and Beverage | $10,450.02 |
| Travel and Lodging | $1,725.87 |
| Education | $423.96 |
| Gift | $19.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11,233.14 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Onmark, INC. | $3,184.02 | 2025 | |
| Novartis Pharmaceuticals Corporation | $1,450.94 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,195.99 | 2019-2025 | Opdivo, Opdualag |
| Janssen Biotech, INC. | $1,022.74 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| Genzyme Corporation | $876.37 | 2019-2025 | |
| Genentech USA, INC. | $869.09 | 2019-2025 | Polivy, Lunsumio, Alecensa |
| Merck Sharp & Dohme LLC | $785.28 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $716.83 | 2019-2025 | |
| Octapharma USA, INC. | $649.83 | 2020-2021 | |
| Exelixis INC. | $558.52 | 2019-2025 | Cabometyx |
| Incyte Corporation | $524.79 | 2019-2024 | Jakafi, Monjuvi, Pemazyre |
| Daiichi Sankyo INC. | $501.29 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Tersera Therapeutics LLC | $493.24 | 2019-2025 | Quzyttir |
| Seagen INC. | $450.45 | 2019-2023 | Tukysa, Adcetris |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $440.93 | 2019-2025 | Vyloy, Xtandi, Xospata |
| Gilead Sciences, INC. | $405.95 | 2019-2025 | Trodelvy |
| Celgene Corporation | $397.19 | 2019-2024 | Reblozyl, Opdualag, Pomalyst |
| Taiho Oncology, INC. | $379.00 | 2019-2025 | |
| Abbvie INC. | $356.59 | 2019-2025 | Venclexta |
| Stemline Therapeutics INC. | $327.91 | 2020-2025 | Orserdu, Elzonris |
| Pharmacyclics LLC, An Abbvie Company | $324.63 | 2019-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $319.62 | 2019-2025 | |
| Lilly USA, LLC | $317.86 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $261.81 | 2019-2025 | |
| Array Biopharma INC | $260.65 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Kite Pharma, INC. | $247.19 | 2020-2025 | Yescarta |
| Regeneron Healthcare Solutions, INC. | $240.37 | 2021-2025 | Libtayo |
| Jazz Pharmaceuticals INC. | $233.91 | 2019-2025 | |
| Puma Biotechnology, INC. | $232.17 | 2020-2025 | |
| Beigene USA, INC. | $228.08 | 2020-2024 | Brukinsa |
| Glaxosmithkline, LLC. | $223.48 | 2020-2025 | Ojjaara, Benlysta |
| Takeda Pharmaceuticals U.S.A., INC. | $202.23 | 2019-2025 | Fruzaqla, Ninlaro |
| Emd Serono, INC. | $176.74 | 2019-2025 | Bavencio, Tepmetko |
| Foundation Medicine, INC. | $153.21 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.47 | 2019-2025 | |
| Deciphera Pharmaceuticals INC. | $124.20 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Siemens Medical Solutions USA, INC. | $113.67 | 2024 | Truebeam, Aria Radiation Therapy Management Software |
| Aveo Pharmaceuticals, INC. | $100.47 | 2023-2025 | Fotivda |
| Acrotech Biopharma INC. | $98.86 | 2021-2025 | Beleodaq |
| Sun Pharmaceutical Industries INC. | $92.80 | 2019-2024 | Odomzo, Yonsa |
| Blueprint Medicines Corporation | $87.18 | 2021-2023 | Ayvakit |
| Adc Therapeutics America, INC. | $86.19 | 2022-2025 | |
| Beone Medicines USA, INC. | $85.05 | 2025 | Brukinsa |
| Mirati Therapeutics, INC. | $83.46 | 2023-2024 | Krazati |
| Amgen INC. | $77.68 | 2019-2023 | Kyprolis, Blincyto |
| Adaptive Biotechnologies Corporation | $77.61 | 2021-2023 | Clonoseq |
| Geron Corporation | $74.16 | 2025 | Rytelo |
| Genmab U.S., INC. | $72.42 | 2023-2025 | Epkinly |
| Sanofi-Aventis U.S. LLC | $69.99 | 2023 | |
| Karyopharm Therapeutics INC. | $68.37 | 2020-2023 | Xpovio |
| Alexion Pharmaceuticals, INC. | $68.17 | 2021-2024 | Ultomiris |
| Iovance Biotherapeutics, INC. | $62.90 | 2025 | Amtagvi |
| Sobi, INC | $61.12 | 2024-2025 | |
| Myovant Sciences INC. | $58.36 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $55.05 | 2020-2025 | Onivyde, Somatuline Depot |
| Servier Pharmaceuticals LLC | $51.69 | 2021-2025 | |
| Rigel Pharmaceuticals, INC. | $51.52 | 2021-2023 | Tavalisse, Rezlidhia |
| Azurity Pharmaceuticals, INC. | $38.87 | 2025 | Danziten |
| Verity Pharmaceuticals INC. | $38.68 | 2025 | Trelstar |
| Recordati_rare_diseases_inc. | $38.55 | 2025 | Sylvant |
| Boston Scientific Corporation | $29.71 | 2025 | Solyx Sis System |
| Epizyme, INC. | $28.05 | 2021-2022 | |
| Fennec Pharmaceuticals, INC. | $27.96 | 2024 | Pedmark |
| Sandoz INC. | $26.64 | 2020-2021 | |
| Pharmaessentia USA Corporation | $25.62 | 2025 | Besremi |
| Amag Pharmaceuticals, INC. | $24.28 | 2019-2021 | |
| Fresenius Kabi USA, LLC | $23.51 | 2024 | Stimufend |
| Lexicon Pharmaceuticals, INC. | $21.25 | 2020 | |
| Myriad Genetic Laboratories, INC. | $19.53 | 2023 | Precisetumor |
| Springworks Therapeutics, INC. | $19.28 | 2025 | Ogsiveo |
| Advanced Accelerator Applications | $17.85 | 2019 | |
| Sumitomo Pharma America, INC. | $16.87 | 2023 | Orgovyx |
| Organon LLC | $16.61 | 2024 | |
| Dendreon Pharmaceuticals LLC | $16.11 | 2020 | |
| Eusa Pharma (US) LLC | $15.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.94 | 2020 | |
| Accord Healthcare, INC. | $15.93 | 2023 | |
| Seqirus USA INC | $14.49 | 2019 | |
| G1 Therapeutics, INC. | $14.37 | 2023 | Cosela |
| Coherus Oncology, INC. | $14.30 | 2024 | |
| Heron Therapeutics, INC. | $13.27 | 2020 | |
| Morphosys, US INC. | $13.15 | 2022 | |
| Spectrum Pharmaceuticals INC. | $12.78 | 2023 | Rolvedon |
| Tesaro, INC. | $11.96 | 2019 | |
| Kyowa Kirin, INC. | $11.18 | 2019 | |
| Secura Bio, INC. | $9.04 | 2020 | |
| Clovis Oncology, INC. | $7.93 | 2019 | |
| Aspira Women'S Health INC | $7.46 | 2024 | Ova1 |
Drugs and devices associated with these payments
Imfinzi $9,290Quzyttir $449Keytruda $358Kisqali $334Tukysa $310Enhertu $303Orserdu $259Imbruvica $238Opdivo $224Xtandi $221Opdualag $217Nubeqa $208Ibrance $208Verzenio $194Libtayo $191Xofigo $188Brukinsa $184Jevtana $182Adcetris $173Jaypirca $170Trodelvy $169Yescarta $163Erleada $159Braftovi $158Fabhalta $158Orgovyx $150Darzalex $150Elrexfio $147Polivy $145Epkinly $144Mektovi $139Venclexta $136Lonsurf $127Inqovi $127Scemblix $125Talzenna $123Reblozyl $114Retevmo $113Welireg $110Injectafer $108Piqray $106Bosulif $104Fotivda $100Fruzaqla $100Lorbrena $95.24Lunsumio $90.06Zepzelca $88.49Truebeam $84.22Beleodaq $83.81Krazati $83.46Comirnaty $83.13Tecvayli $82.60Cabometyx $79.61Lynparza $77.57Odomzo $77.49Yonsa $77.49Vyloy $75.97Lenvima $74.78Rytelo $74.16Rozlytrek $73.79Avastin $73.79Alecensa $73.79Tecentriq $73.79Sarclisa $73.29Promacta $72.13Ojjaara $64.74Amtagvi $62.90Paxlovid $58.17Datroway $57.31Qinlock $56.21Elzonris $55.49Columvi $54.80Gavreto $54.60Besponsa $53.36Talvey $53.30Xalkori $51.63Padcev $47.61Inlyta $46.42Nerlynx $41.43Onivyde $41.10Ultomiris $40.66Calquence $39.89Emrelis $39.52Danziten $38.87Pomalyst $38.87Trelstar $38.68Sylvant $38.55Tasigna $38.36Ayvakit $37.14Clonoseq $35.07Tagrisso $34.57Jakafi $32.25Vanflyta $31.48Bavencio $29.87Solyx Sis System $29.71Aria Radiation Therapy Management Software $29.45Mekinist $28.94Pedmark $27.96Akeega $25.92Balversa $25.92
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Squires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.